Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3-hydroxytamoxifen
2. 3-hydroxytamoxifen Citrate
3. Droloxifene
4. Fk 435
5. Fk-435
6. Fk435
7. Meta-hydroxytamoxifen
1. 97752-20-0
2. Droloxifene Citrate [usan]
3. Droloxifenecitrate
4. 6km138nw4b
5. K-060e
6. Droloxifene Citrate (usan)
7. Phenol, 3-(1-(4-(2-(dimethylamino)ethoxy)phenyl)-2-phenyl-1-butenyl)-, (e)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) (salt)
8. 3-hydroxytamoxifen Citrate
9. 3-[(e)-1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol;2-hydroxypropane-1,2,3-tricarboxylic Acid
10. Einecs 307-782-5
11. Unii-6km138nw4b
12. Schembl4192
13. (e)-1-(4'-(2-dimethylaminoethoxy)phenyl)-1-(3-hydroxyphenyl)-2-phenylbut-1-ene Citrate
14. (e)-alpha-(p-(2-(dimethylamino)ethoxy)phenyl)-alpha'-ethyl-3-stilbenol Citrate (1:1) (salt)
15. (e)-alpha-(para-(2-(dimethylamino)ethoxy)phenyl)-alpha'-ethyl-3-stilbenol Citrate (iupac)
16. Trans-1-(4-beta-dimethylaminoethoxyphenyl)-1-(3-hydroxyphenyl)-2-phenylbut-1-ene Citrate
17. Chembl2105786
18. Droloxifene Citrate [mi]
19. (e)-(2-(4-(1-(3-hydroxyphenyl)-2-phenylbut-1-enyl)phenoxy)ethyl)dimethylammonium Dihydrogen 2-hydroxypropane-1,2,3-tricarboxylate
20. D03912
21. Q27265061
22. (e)-.alpha.-(p-(2-(dimethylamino)ethoxy)phenyl)-.alpha.'-ethyl-3-stilbenol Citrate (1:1) (salt)
| Molecular Weight | 579.6 g/mol |
|---|---|
| Molecular Formula | C32H37NO9 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 13 |
| Exact Mass | 579.24683176 g/mol |
| Monoisotopic Mass | 579.24683176 g/mol |
| Topological Polar Surface Area | 165 Ų |
| Heavy Atom Count | 42 |
| Formal Charge | 0 |
| Complexity | 728 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Antioxidants
Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
Estrogen Antagonists
Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. (See all compounds classified as Estrogen Antagonists.)
ABOUT THIS PAGE
A Droloxifene manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Droloxifene, including repackagers and relabelers. The FDA regulates Droloxifene manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Droloxifene API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Droloxifene supplier is an individual or a company that provides Droloxifene active pharmaceutical ingredient (API) or Droloxifene finished formulations upon request. The Droloxifene suppliers may include Droloxifene API manufacturers, exporters, distributors and traders.
click here to find a list of Droloxifene suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Droloxifene DMF (Drug Master File) is a document detailing the whole manufacturing process of Droloxifene active pharmaceutical ingredient (API) in detail. Different forms of Droloxifene DMFs exist exist since differing nations have different regulations, such as Droloxifene USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Droloxifene DMF submitted to regulatory agencies in the US is known as a USDMF. Droloxifene USDMF includes data on Droloxifene's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Droloxifene USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Droloxifene suppliers with USDMF on PharmaCompass.
Droloxifene Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Droloxifene GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Droloxifene GMP manufacturer or Droloxifene GMP API supplier for your needs.
A Droloxifene CoA (Certificate of Analysis) is a formal document that attests to Droloxifene's compliance with Droloxifene specifications and serves as a tool for batch-level quality control.
Droloxifene CoA mostly includes findings from lab analyses of a specific batch. For each Droloxifene CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Droloxifene may be tested according to a variety of international standards, such as European Pharmacopoeia (Droloxifene EP), Droloxifene JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Droloxifene USP).
LOOKING FOR A SUPPLIER?
